{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T01:10:14Z","timestamp":1733793014772,"version":"3.30.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.aace.2024.08.010","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T18:25:55Z","timestamp":1725474355000},"page":"257-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of Nonketotic Hyperglycemia Requiring High-Dose Insulin After Supratherapeutic Amlodipine Ingestion"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1670-572X","authenticated-orcid":false,"given":"Nishant","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihail","family":"Zilbermint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10A","key":"10.1016\/j.aace.2024.08.010_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0002-9149(97)89421-0","article-title":"Effects of calcium antagonists on insulin sensitivity and other metabolic parameters","volume":"79","author":"Sowers","year":"1997","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.aace.2024.08.010_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1475-2840-10-79","volume":"10","author":"Fukao","year":"2011","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"10.1016\/j.aace.2024.08.010_bib3","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/01.CCM.0000278916.04569.23","article-title":"Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil","volume":"35","author":"Levine","year":"2007","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.aace.2024.08.010_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/pdi.2189","article-title":"Amlodipine-induced hyperglycaemia","volume":"35","author":"DeGeeter","year":"2018","journal-title":"Pract Diabetes"},{"key":"10.1016\/j.aace.2024.08.010_bib5","article-title":"Antihypertensive treatment improves glycemic control in patients with newly diagnosed type 2 diabetes mellitus: a prospective cohort study","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.aace.2024.08.010_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12012-017-9419-x","article-title":"A\u00a0case of severe, refractory hypotension after amlodipine overdose","volume":"18","author":"Chudow","year":"2018","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"10.1016\/j.aace.2024.08.010_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/hearts4010001","article-title":"Amlodipine overdose: is high dose insulin ready for prime time","volume":"4","author":"Farmer","year":"2023","journal-title":"Hearts"},{"issue":"3","key":"10.1016\/j.aace.2024.08.010_bib8","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1097\/CCM.0000000000002087","article-title":"Experts consensus recommendations for the management of calcium channel blocker poisoning in adults","volume":"45","author":"St-Onge","year":"2017","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.aace.2024.08.010_bib9","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1080\/15563650.2022.2132768","article-title":"2021 annual report of the National Poison Data System\u00a9 (NPDS) from America\u2019s poison centers: 39th annual report","volume":"60","author":"Gummin","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"year":"2024","series-title":"Calcium Channel Blocker Toxicity","author":"Chakraborty","key":"10.1016\/j.aace.2024.08.010_bib10"},{"issue":"suppl 1","key":"10.1016\/j.aace.2024.08.010_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00129784-200707001-00003","article-title":"Calcium channel blockers: differences between subclasses","volume":"7","author":"Frishman","year":"2007","journal-title":"Am J Cardiovasc Drugs"},{"year":"2023","series-title":"Physiology, Calcium","author":"Yu","key":"10.1016\/j.aace.2024.08.010_bib12"},{"issue":"7","key":"10.1016\/j.aace.2024.08.010_bib13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ccr3.300","article-title":"A\u00a0multifaceted approach to calcium channel blocker overdose: a case report and literature review","volume":"3","author":"Burkes","year":"2015","journal-title":"Clin Case Rep"},{"issue":"11","key":"10.1016\/j.aace.2024.08.010_bib14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/phar.2177","article-title":"An overview of hyperinsulinemic-euglycemic therapy in calcium channel blocker and \u03b2-blocker overdose","volume":"38","author":"Krenz","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.aace.2024.08.010_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/cc4938","article-title":"Bench-to-bedside review: hyperinsulinaemia\/euglycaemia therapy in the management of overdose of calcium-channel blockers","volume":"10","author":"Lheureux","year":"2006","journal-title":"Crit Care"},{"issue":"20","key":"10.1016\/j.aace.2024.08.010_bib16","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1161\/CIRCULATIONAHA.104.497461","article-title":"Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium","volume":"111","author":"von Lewinski","year":"2005","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.aace.2024.08.010_bib17","doi-asserted-by":"crossref","first-page":"16505","DOI":"10.1074\/jbc.M801424200","article-title":"Insulin effects on cardiac Na+\/Ca2+ exchanger activity: role of the cytoplasmic regulatory loop","volume":"283","author":"Villa-Abrille","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.aace.2024.08.010_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/15563650.2011.582471","article-title":"High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning","volume":"49","author":"Engebretsen","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.aace.2024.08.010_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1530-891X(20)46779-5","article-title":"Abstract #435 insulin a potential life \u2013saving medication in a noniabetic patient: a case of calcium channel blocker overdose","volume":"25","author":"Murati","year":"2019","journal-title":"Endocr Pract"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237606052400097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237606052400097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:37:39Z","timestamp":1733791059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S237606052400097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S237606052400097X"],"URL":"https:\/\/doi.org\/10.1016\/j.aace.2024.08.010","relation":{},"ISSN":["2376-0605"],"issn-type":[{"type":"print","value":"2376-0605"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Nonketotic Hyperglycemia Requiring High-Dose Insulin After Supratherapeutic Amlodipine Ingestion","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aace.2024.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}